BioResource scientific conference returns for 2026
Join us for the fourth edition of the NIHR BioResource Scientific Conference on Wednesday 17th June.
STORM Therapeutics secures $56 million series C financing and doses first patient in phase 2 Sarcoma Trial of STC‑15
The proceeds will support the advancement of STC-15 in a Phase 2 study in select sarcoma indicationsFirst‑in‑class METTL3 inhibitor reprograms malignant progenitor cells by modulating mRNA methylation16 April 2026, Cambridge, UK: STORM Therapeutics Ltd.
Bridging Cambridge’s MedTech scale-up gap: the missing link between prototype and production
Cambridge leads in early-stage MedTech innovation, but many promising ideas stall when moving from lab prototypes to clinical-ready devices. The core challenge lies in fragmented, early-stage manufacturing and regulatory pathways, often pushing companies to look overseas. This reflects a broader UK gap in scaling MedTech innovation.
The retinal delivery bottleneck: why today’s tools won’t scale
Cell and gene therapies make up a large and growing proportion of pipeline treatments for high-prevalence diseases of the retina. For these advanced therapies to deliver on their promise, most need to be delivered into the retina, overcoming significant physiological barriers. But existing retinal delivery is a slow, skilled, small-scale business: enabling patients with high-prevalence diseases…
'Addenbrooke's saved my twin sister - and her baby': the powerful stories inspiring Addenbrooke’s Charitable Trust’s TCS London Marathon runners
Addenbrooke's Charitable Trust (ACT) has a record 18 runners in this year's TCS London Marathon. Not only that - but to date they have also raised a record £54,000 between them. To hear their stories, and to find out why they are running to raise funds for Addenbrooke's and the Rosie, see below.
Supporting busy teams with practical 90-minute Microsoft Copilot training
Help your team save time, reduce manual work, and get more from Microsoft Copilot. These 90-minute, instructor-led sessions focus on practical skills your team can start using immediately in Excel, Word and PowerPoint.
Atelerix forms strategic partnership with JH Health Ltd to expand non-cryogenic cell preservation capabilities in the Middle East
Agreement grants JH Health exclusive rights to use and distribute Atelerix’s portfolio of non-cryogenic preservation solutions in the regionExpands regional capabilities with funding for high-volume local manufacturing, as well as relevant regulatory filings and researc
CJ & L Consultancy Ltd announces strategic partnership with ISMS.online (IO) to strengthen cyber security and medical device compliance
CJ & L Consultancy Ltd, a specialist consultancy providing expert guidance in medical device quality, regulatory compliance, and information security, is pleased to announce a strategic partnership with ISMS.online, a leading provider of Information Security Management System (ISMS) software. The partnership enhances CJ & L Consultancy Ltd’s ability to support organisations seeking Cyber…
Lightcast Raises $27 Million and Adds Industry Veteran to Accelerate Commercialization of Envisia™ Platform
· Proceeds will help enhance workflows and expand single-cell functional assay portfolio
· Brad Crutchfield joins as advisor to support early access growth and global launch
Bio-Rad extends range of anti-idiotypic antibodies and anti-Fc mutation antibodies for bioanalysis and drug monitoring
Expanded antibody portfolio enhances detection of biologics and YTE-modified therapeutics for bioanalytical applications
ELRIG announces inaugural US Drug Discovery Conference
• Free-to-attend event takes place at Pfizer in Cambridge, MA from 16–17 June • Drug Discovery USA 2026 to focus on emerging multifunctional small molecule and biologic approaches to drug difficult targets
OBN rebrands to BioUK in alignment with its mission to catalyse success in UK life sciences
· The new name reflects the national reach of the UK life science membership organisation and leverages its wide and long-established portfolio of Bio-prefixed events
ProImmune collaborates with The University of Texas Medical Branch to Advance Infectious Disease Research
Development of novel Ankyrons will enable study of emerging high-consequence infectious diseases to inform vaccines and treatments
VALANX Biotech establishes Scientific Advisory Board to advance ADC therapeutics
John Lambert, Morris Rosenberg and Peter de Waele appointed as Chair and members of the SAB respectivelySAB provides scientific expertise and drug development experience, supporting advancement of the Company’s GoldenSite™ conjugation platform and its LIV-1 targeting le
Oil, Inflation, and the innovation budget question: what UK-China life sciences collaboration looks like when conditions tighten
Excellence First Enterprise Consultancy (EFEC). When oil moves sharply, life sciences people can be tempted to see it as someone else’s problem. Energy is macroeconomics; biotech and MedTech are innovation. But that separation is usually an illusion.
SPT Labtech and EMBL GeneCore collaborate to advance fully walkaway automation in genomics workflows
firefly+ liquid handling platform installed at EMBL GeneCoreCollaboration to enable more streamlined end-to-end workflows while maintaining sample integrityCambridge, UK, and Heidelberg, Germany, 13 April 2026: SPT Labtech, a global le
FairJourney Bio opens Cryo-EM structural biology facility in San Diego
Antibody discovery expert expands presence in US biotech ecosystem with world-leading atomic-resolution structural biology capabilities
Mark Wheeler announced as new Managing Director as Guardtech mark beginning of new era with company rebrand
The Suffolk-based cleanroom construction specialists’ family of brands will all fall under the simplified umbrella title of ‘Guardtech’ from now on
Webinar: When Hits Don’t Translate – Challenging Membrane Targets from GPCRs to CD3–TCR
How target presentation and environment shape epitope access, selection outcomes, and functional screening.
Genome loaded onto a quantum computer in world first
Sanger Institute team and their collaborators have successfully loaded the Hepatitis D viral genome on a quantum computer.
William Blair analysts name Carterra a winner in life science tools for enabling AI drug discovery at unprecedented scale
Carterra, with its HT-SPR technology platforms, is listed alongside large public companies as a technology provider to capitalize on the likely growth in wet lab work driven by the increasing use of AI in early discovery
Virica Biotech and FUJIFILM Biosciences Collaborate Under the Canada–Japan Co-Innovation Program to Advance AAV Production Enhancers
Efficient production of Adeno-Associated Virus (AAV) vectors at scale for in vivo gene therapies remains a key bottleneck for broad patient access and sustainable manufacturing costs
Planning permission granted for relocation of lifesaving charity’s air base
East Anglian Air Ambulance has been granted planning permission for the relocation of its air base in Cambridgeshire.
Campaign days: Game-changer or just more noise?
Mental Health Awareness Week in May - How will you take action?
Landmark UK study could change child brain injury treatment
Researchers are calling for a re-evaluation of guidelines used in the care of children with traumatic head injuries following the first multi-centre study of its kind in the UK.